Gurgaon, India
Dr Lal PathLabs is the largest and most respected diagnostic service provider in India, established in 1949. With a pan India presence and international operations in Nepal and Bangladesh, the company offers a wide range of diagnostic tests and services. Serving over 13 million customers annually, it has over 190 labs and 2000 centers across India.
Dr Lal PathLabs is known for its strict adherence to international standards and has been accredited by reputable bodies such as the College of American Pathologists, NABL, Ministry of Science and Technology, and ISO 9001:2000 certification. The company covers a broad spectrum of disciplines including Molecular Diagnostics, Biophysics, Immunophenotying, Oncology, Biochemistry, and more.
The company's last investment round amounted to $1.91B in December 2015, with notable investors such as T. Rowe Price, Fidelity, Reliance Capital, State Bank of India, Kotak Mahindra Bank, JP Morgan Chase, DSP Blackrock, Birla Sun Life Insurance, and ICICI Prudential Mutual Fund.
Dr Lal PathLabs continues to uphold its slogan to achieve excellence in diagnostic testing, information, and services as it solidifies its position in the biotechnology and healthcare industries.
